File Download
  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Efficacy and tolerability of sorafenib in elderly patients with advanced hepatocellular carcinoma

TitleEfficacy and tolerability of sorafenib in elderly patients with advanced hepatocellular carcinoma
Authors
Wong, HYau, CCYao, TTang, VChan, PChiu, JFan, STPoon, R
KeywordsMedical sciences
Oncology medical sciences
Radiology and nuclear medicine pharmacy and pharmacology biology
Cytology and histology
Issue Date2010
PublisherAmerican Society of Clinical Oncology. The Journal's web site is located at http://www.jco.org/
Citation
The 46th Annual Meeting of the American Society of Clinical Oncology (ASCO 2010), Chicago, IL., 4-8 June 2010. In Journal of Clinical Oncology, 2010, v. 28 n. 15 suppl., abstract no. e14522 How to Cite?
AbstractBACKGROUND: With the aging population, malignancies, including hepatocellular carcinoma (HCC) in the elderly represent a significant health burden. The perception that older cancer patients may be at higher risk than younger patients of toxic effects from cancer therapy but may obtain less clinical benefit from it is mainly due to known toxic effects of cytotoxic chemotherapy. It is not known how older patients respond to targeted therapy. We aim to evaluate and compare the efficacy and tolerability of single agent sorafenib in treating elderly and younger patients with …
DescriptionThis journal suppl. contain abstracts of ASCO 2010
Open Access Journal
Persistent Identifierhttp://hdl.handle.net/10722/186578
ISSN
0732-183X
2023 Impact Factor: 42.1
2023 SCImago Journal Rankings: 10.639

 

DC FieldValueLanguage
dc.contributor.authorWong, Hen_US
dc.contributor.authorYau, CCen_US
dc.contributor.authorYao, Ten_US
dc.contributor.authorTang, Ven_US
dc.contributor.authorChan, Pen_US
dc.contributor.authorChiu, Jen_US
dc.contributor.authorFan, STen_US
dc.contributor.authorPoon, Ren_US
dc.date.accessioned2013-08-20T12:14:07Z-
dc.date.available2013-08-20T12:14:07Z-
dc.date.issued2010en_US
dc.identifier.citationThe 46th Annual Meeting of the American Society of Clinical Oncology (ASCO 2010), Chicago, IL., 4-8 June 2010. In Journal of Clinical Oncology, 2010, v. 28 n. 15 suppl., abstract no. e14522en_US
dc.identifier.issn0732-183X-
dc.identifier.urihttp://hdl.handle.net/10722/186578-
dc.descriptionThis journal suppl. contain abstracts of ASCO 2010-
dc.descriptionOpen Access Journal-
dc.description.abstractBACKGROUND: With the aging population, malignancies, including hepatocellular carcinoma (HCC) in the elderly represent a significant health burden. The perception that older cancer patients may be at higher risk than younger patients of toxic effects from cancer therapy but may obtain less clinical benefit from it is mainly due to known toxic effects of cytotoxic chemotherapy. It is not known how older patients respond to targeted therapy. We aim to evaluate and compare the efficacy and tolerability of single agent sorafenib in treating elderly and younger patients with …-
dc.languageengen_US
dc.publisherAmerican Society of Clinical Oncology. The Journal's web site is located at http://www.jco.org/-
dc.relation.ispartofJournal of Clinical Oncologyen_US
dc.subjectMedical sciences-
dc.subjectOncology medical sciences-
dc.subjectRadiology and nuclear medicine pharmacy and pharmacology biology-
dc.subjectCytology and histology-
dc.titleEfficacy and tolerability of sorafenib in elderly patients with advanced hepatocellular carcinomaen_US
dc.typeConference_Paperen_US
dc.identifier.emailYau, CC: tyaucc@hku.hken_US
dc.identifier.emailYao, T: tjyao@hku.hken_US
dc.identifier.emailFan, ST: stfan@hku.hken_US
dc.identifier.emailPoon, R: poontp@hku.hken_US
dc.identifier.authorityYau, CC=rp01466en_US
dc.identifier.authorityYao, T=rp00284en_US
dc.identifier.authorityFan, ST=rp00355en_US
dc.identifier.authorityPoon, R=rp00446en_US
dc.description.naturelink_to_OA_fulltext-
dc.identifier.hkuros217129en_US
dc.identifier.volume28-
dc.identifier.issue15 suppl.-
dc.publisher.placeUnited States-
dc.customcontrol.immutablesml 131007-
dc.identifier.issnl0732-183X-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats